They can be effective for short-term insomnia on GLP-1 , helping to break the cycle of sleeplessness and re-establish a healthy sleep pattern
Retatrutide also demonstrated strong metabolic improvements beyond weight
However, this slower digestion is also the primary reason for symptoms like nausea, bloating, and changes in bowel habits that people experience
Tirzepatides dual GLP-1 and GIP receptor activity translates into enhanced metabolic and weight-loss benefits compared to GLP-1 monotherapy. While semaglutide remains a trusted choice for both diabetes and obesity, these findings suggest tirzepatide may offer an extra edge
But theyre not meant to be a long-term solution when FDA-approved options are available
Ghosh anticipates that the pharma companies and their stacked legal teams, rather than the FDA, will end up driving how long those personalized doses can remain available